Differential contribution of IL-1Ra isoforms to allele-specific IL-1Ra mRNA accumulation

Journal of Interferon and Cytokine Research

Volumn 24, Issue 4, 2004, Pages 253-260

  Redlitz, Karen H ^a   Yamshchikov, Vladimir F ^a   Cominelli, Fabio ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ISOPROTEIN; MESSENGER RNA;

ALLELE; ARTICLE; CELL; COLON BIOPSY; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HYPOTHESIS; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; INTRON; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; TISSUE; TRANSCRIPTION REGULATION;

ALLELES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTRONS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RNA, MESSENGER; SIALOGLYCOPROTEINS;

EID: 1942516999     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999004323034123     Document Type: Article

References (37)

1. DINARELLO, C.A. (1996). Biological basis for interleukin-1 in disease. Blood 87, 2095-2147.
2. ROUX-LOMBARD, P. (1998). The interleukin-1 family. Eur. Cytokine Netw. 9, 565-576.
3. ROSENWASSER, L.J. (1998). Biologic activities of IL-1 and its role in human disease. J. Allergy Clin. Immunol. 102, 344-350.
4. AREND, W.P., MALYAK, M., GUTHRIDGE, C.J., and GABAY, C. (1998). Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16, 27-55.
5. DINARELLO, C.A. (2000). The role of the interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1. N. Engl. J. Med. 343, 732-734.
6. LIAO, Z., HAIMOVITZ, A., CHEN, Y., CHAN, J., and ROSENSTREICH, D.L. (1985). Characterization of a human interleukin 1 inhibitor. J. Immunol. 134, 3882-3886.
7. HANNUM, C.H., WILCOX, C.J., AREND, W.P., JOSLIN, F.G., DRIPPS, D.J., HEIMDAL, P.L., ARMES, L.G., SOMMER, A., EISENBERG, S.P., and THOMPSON, R.C. (1990). Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343, 336-340.
8. HASKILL, S., MARTIN, G., VANLE, L., MORRIS, J., PEACE, A., BIGLER, C.F., JAFFE, G.J., HAMMERBERG, C., SPORN, S.A., FONG, S., AREND, W.P., and RALPH, P. (1991). cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. USA 88, 3681-3685.
9. MUZIO, M., POLANTARUTTI, N., SIRONI, M., POLI, G., DEGIOIA, L., INTRONA, M., MONTOVANI, A., and COLOTTA, F. (1995). Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist. J. Exp. Med. 182, 623-628.
10. WEISSBACH, L., TRAN, K., COLQUHOUN, S.A., CHAMPLIAUD, M.F., and TOWLE, C.A. (1998). Detection of an interleukin-1 intracellular receptor antagonist mRNA variant. Biochem. Biophys. Res. Commun. 244, 91-95.
11. HOLTKAMP, G.M., DEVOS, A.F., KIJLSTRA, A., and PEEK, R. (1999). Expression of multiple forms of IL-1 receptor antagonist (IL-1Ra) by human retinal pigment epithelial cells: identification of a new IL-1Ra exon. Eur. J. Immunol. 29, 215-222.
12. STEINKASSERER, A., KOELBLE, K., and SIM, R.B. (1991). Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (ILIRN). Nucleic Acids Res. 19, 5095.
13. TARLOW, J.K., BLAKEMORE, A.I.F., LENNARD, A., SOLARI, R., HUGHES, H.N., STEINKASSERER, A., and DUFF, G.W. (1993). Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet. 91, 403-404.
14. ROUSSOMOUSTAKAKI, M., SATSANGI, J., WELSH, K., LOUIS, E., FANNING, G., TARGAN, S., LANDERS, C., and JEWELL, D.P. (1997). Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 112, 1845-1853.
15. NEMETZ, A., KOPE, A., MOLNAR, T., KOVACS, A., FEHER, J., TULASSAY, Z., NAGY, F., GARCIA-GONZALEZ, M.A., and PENA, A.S. (1999). Significant differences in the interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease. Scand J. Gastroenterol. 34, 175-179.
16. CLAY, F.E., TARLOW, J.K., CORK, M.J., COX, A., NICKLIN, M.J.H., and DUFF, G.W. (1996). Novel interleukin-1 receptor antagonist polymorphisms and their use in allele-specific mRNA assessment. Hum. Genet. 97, 723-726.
17. GUASCH, J.F., BERTINA, R.M., and REITSMA, P.H. (1996). Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. Cytokine 8, 598-602.
18. BUTCHER, C., STEINKASSERER, A., TEJURA, S., and LENNARD, A.C. (1994). Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist. J. Immunol. 153, 701-711.
19. SMITH, M.F., Jr., AREND, W.P., and GUTIERREZ-HARTMANN, A. (1991). Isolation and characterization of the IL-1Ra promoter. FASEB 5, A970.
20. JENKINS, J.K., DRONG, R.F., SHUCK, M.E., BIENKOWSKI, M.J., SLIGHTOM, J.L., AREND, W.P., and SMITH, M.F., Jr. (1997). Intracellular IL-1 receptor antagonist promoter: cell type-specific and inducible regulatory regions. J. Immunol. 158, 748-755.
21. LA, E., and FISCHER, S.M. (2001). Transcriptional regulation of intracellular IL-1 receptor antagonist gene by IL-1 alpha in primary mouse keratinocytes. J. Immunol. 166, 6149-6155.
22. DANIS, V.A., MILLINGTON, M., HYLAND, V.J., and GRENNAN, D. (1995). Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin. Exp. Immunol. 99, 303-310.
23. VAMVAKOPOULOS, J., GREEN, C., and METCALFE, S. (2002). Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur. J. Immunol. 32, 2988-2996.
24. BARTON, P.T., GERBER, S., SKUPSKI, D.W., and WITKIN, S.S. (2003). Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, and vaginal Ureaplasma urealyticum colonization in pregnant women. Infect. Immun. 71, 271-274.
25. ANDUS, T., DAIG, R., VOGL, D., ASCHENBRENNER, E., LOCK, G., HOLLERBACH, S., KOLLINGER, M., SCHOLMERICH, J., and GROSS, V. (1997). Imbalance of the interleukin 1 system in colonic mucosa - association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2. Gut 41, 651-657.
26. CARTER, M.J., JONES, S., DIGIOVINE, F.S., CAMP, N.J., LOBO, A.J., and DUFF, G.W. (1998). Allele 2 of the interleukin-1 receptor antagonist gene polymorphism is associated with reduced expression of interleukin-1 receptor antagonist in ulcerative colitis. Gastroenterology 114, A947.
27. TOUNTAS, N., CASINI-RAGGI, V., and COMINELLI, F. (1999). Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 117, 806-813.
28. LIU, Z., YANG, J., CHEN, Z., GONG, R., and LI, L. (2001). Gene polymorphisms in IL-1 receptor antagonist affects its production by monocytes in IgA nephropathy and Henoch-Schonlein nephritis. Chin. Med. J. 114, 1313-1316.
29. CARTER, M.J., DUFF, G.W., and DIGIOVINE, F.S. (1999). Allele-specific mRNA assessment in colonic mucosa I ulcerative colitis: association of the interleukin receptor antagonist gene allele 2 with reduced steady-state mRNA levels. Gastroenterology 116, A677.
30. NISHIYAMA, T., MITSUYAMA, K., TOYONAGA, A., SASAKI, E., and TANIKAWA, K. (1994). Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease. Digestion 55, 368-373.
31. WETZLER, M., KURZROCK, R., ESTROV, Z., KANTARJIAN, H., GISSLINGER, H., UNDERBRINK, M.P., and TALPAZ, M. (1994). Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates. Blood 84, 3142-3147.
32. SHINGU, M., FUJIKAWA, Y., WADA, T., NONAKA, S., and NOBUNAGA, M. (1995). Increased IL-1 receptor antagonist (IL-1Ra) production and decreased IL-1 beta/IL-1Ra ratio in mononuclear cells from rheumatoid arthritis patients. Br. J. Rheumatol. 34, 24-30.
33. CASINI-RAGGI, V., KAM, L., CHONG, Y.J.T., FIOCCHI, C., PIZARRO, T.T., and COMINELLI, F. (1995). Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J. Immunol. 154, 2434-2440.
34. TILLIE-LEBLOND, I., PUGIN, J., MARQUETTE, C.H., LAMBLIN, C., SAULNIER, F., BRICHET, A., WALLAERT, B., TONNEL, A.B., and GOSSET, P. (1999). Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am. J. Respir. Crit. Care Med. 159, 487-494.
35. TSAO, T.C., HONG, J., LI, L.F., HSIEH, M.J., LIAO, S.K., and CHANG, K.S. (2000). Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis. Chest 117, 103-109.
36. YE, J., and YOUNG, H.A. (1997). Negative regulation of cytokine gene transcription. FASEB J. 11, 825-833.
37. FIERING, S., WHITELAW, E., and MARTIN, D.I. (2000). To be or not to be active: the stochastic nature of enhancer action. Bioessays 22, 381-387.